Department of Medicine, Shellharbour Hospital, Illawarra, New South Wales, Australia.
Intern Med J. 2023 Dec;53(12):2277-2282. doi: 10.1111/imj.16151. Epub 2023 Jun 21.
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycaemic state (HHS) are medical emergencies requiring prompt assessment and management to avoid complications.
To examine adherence to the hospital DKA/HHS insulin infusion protocol, assess outcomes in patients admitted with DKA or HHS, and determine if improvements have been observed from a similar audit in 2016.
An audit was conducted on 40 patients admitted to Shellharbour Hospital with DKA or HHS. Protocol adherence was assessed in the domains of fluid replacement, potassium replacement, use of the correct insulin infusion schedule, timing of commencement of dextrose infusion and appropriate transition to subcutaneous insulin. The outcomes assessed included length of hospital stay, duration of insulin infusion, time to euglycaemia, intensive care unit (ICU) transfer, overlap between insulin infusion and subcutaneous insulin, diabetes team review and incidence and management of hypoglycaemia.
The proportion of cases that adhered to the components of the insulin infusion protocol is as follows: fluid replacement (40%), potassium replacement (72.5%), correct insulin schedule (82.5%), appropriate commencement of intravenous dextrose (80%) and appropriate transition to subcutaneous insulin (87.5%). Appropriate overlap between insulin infusion and subcutaneous insulin occurred in 62.5% of patients. Eighty-five per cent of patients were reviewed by the diabetes team. Three per 40 patients experienced hypoglycaemia, and none of the three patients was treated as per protocol. Compared to the 2016 audit, there was a significant improvement in potassium replacement but a decrease in appropriate fluid replacement.
This audit highlights areas in DKA/HHS management requiring improvement. These include fluid and potassium replacement and appropriate overlap between subcutaneous insulin and insulin infusion.
糖尿病酮症酸中毒(DKA)和高渗性高血糖状态(HHS)是需要迅速评估和治疗以避免并发症的医学急症。
检查遵守医院 DKA/HHS 胰岛素输注方案的情况,评估因 DKA 或 HHS 入院的患者的结局,并确定与 2016 年类似的审核相比是否观察到了改进。
对因 DKA 或 HHS 而入住 Shellharbour 医院的 40 名患者进行了审核。在液体替代、钾替代、使用正确的胰岛素输注方案、开始输注葡萄糖的时间以及适当过渡到皮下胰岛素等方面评估了方案的遵守情况。评估的结局包括住院时间、胰岛素输注时间、血糖正常化时间、转入重症监护病房(ICU)、胰岛素输注和皮下胰岛素重叠、糖尿病团队评估以及低血糖的发生率和管理。
遵守胰岛素输注方案各组成部分的病例比例如下:液体替代(40%)、钾替代(72.5%)、正确的胰岛素方案(82.5%)、适当开始静脉输注葡萄糖(80%)和适当过渡到皮下胰岛素(87.5%)。在 62.5%的患者中发生了适当的胰岛素输注和皮下胰岛素重叠。85%的患者接受了糖尿病团队的评估。40 名患者中有 3 名发生低血糖,且均未按方案进行治疗。与 2016 年的审核相比,钾替代有显著改善,但适当的液体替代减少。
本次审核突出了 DKA/HHS 管理中需要改进的领域。这些领域包括液体和钾替代以及皮下胰岛素和胰岛素输注之间的适当重叠。